M.D.-Ph.D.'s Succeed In Biomedical Arena, Even As Doubts Persist Over Their Role

Ferid Murad, M.D., Ph.D., just won the Nobel Prize for physiology or medicine for his work on nitric oxide. Francis Collins, M.D., Ph.D., heads the National Human Genome Research Institute. And 49 investigators who hold both M.D. and Ph.D. degrees are funded by the prestigious Howard Hughes Medical Institute. What these disparate observations reflect is the rise of the M.D.-Ph.D., whose training and professional pedigree dovetail nicely with two hallmarks of the current biomedical arena: rapid

Written byDouglas Steinberg
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Ferid Murad, M.D., Ph.D., just won the Nobel Prize for physiology or medicine for his work on nitric oxide. Francis Collins, M.D., Ph.D., heads the National Human Genome Research Institute. And 49 investigators who hold both M.D. and Ph.D. degrees are funded by the prestigious Howard Hughes Medical Institute.

What these disparate observations reflect is the rise of the M.D.-Ph.D., whose training and professional pedigree dovetail nicely with two hallmarks of the current biomedical arena: rapid advances in disease-related research and expansion efforts under way at many medical centers. Enrollment in M.D.-Ph.D. programs has ballooned over the past decade, and some M.D.-Ph.D.s match or outperform Ph.D.s on certain measures of career success, according to a new study.

Nevertheless, troubling questions remain about the role and future of M.D.-Ph.D.s. Some proponents of dual-degree programs expected graduates to bolster the ranks of clinician-scientists. Instead, most M.D.-Ph.D.s turn to basic research after completing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies